Drug Profile
Research programme: mGLUR1/5 antagonists - AbbVie/Gedeon Richter
Latest Information Update: 18 May 2020
Price :
$50
*
At a glance
- Originator Gedeon Richter
- Developer AbbVie; Gedeon Richter
- Class
- Mechanism of Action Metabotropic glutamate receptor 5 antagonists; Metabotropic glutamate receptor type 1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Anxiety disorders; CNS disorders; Major depressive disorder
Most Recent Events
- 08 May 2020 Allergan has been acquired and merged into AbbVie
- 04 Nov 2017 No recent reports of development identified for preclinical development in Anxiety-disorders in Hungary
- 04 Nov 2017 No recent reports of development identified for preclinical development in Anxiety-disorders in USA